VA
VR Adviser Portfolio holdings
AUM
$1.78B
1-Year Est. Return
45.24%
1 Year Est. Return
+45.24%
AUM
$1.78B
AUM Growth
+$442M
(+33%)
Holding
33
Top Buys
| 1 | +$31.9M | |
| 2 | +$29.5M | |
| 3 | +$24.4M | |
| 4 |
Savara
SVRA
|
+$13.6M |
| 5 |
CytomX Therapeutics
CTMX
|
+$5.08M |
Top Sells
| 1 | +$65.3M | |
| 2 | +$34.3M | |
| 3 | +$21.2M | |
| 4 |
Enliven Therapeutics
ELVN
|
+$16.4M |
| 5 |
Cogent Biosciences
COGT
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 99.55% |
| 2 | Financials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
26
Crescent Biopharma
CBIO
$418M
| $16.5M | 0.93% |
1,387,864
|
|
||
|
SEPN
27
Septerna Inc
SEPN
$1.18B
| $11.5M | 0.65% |
610,808
+70,355
|
|
||
28
Cullinan Oncology
CGEM
$685M
| $8.18M | 0.46% |
1,379,965
|
|
||
29
Surrozen
SRZN
$164M
| $8.16M | 0.46% |
632,931
|
|
||
|
PCSC
30
Perceptive Capital Solutions
PCSC
$151M
| $7.95M | 0.45% |
750,000
|
|
||
|
ARTV
31
Artiva Biotherapeutics
ARTV
$117M
| $4.62M | 0.26% |
1,609,569
|
|
||
32
Tenax Therapeutics
TENX
$97.1M
| $3.33M | 0.19% |
437,708
+339,144
|
|
||
33
CASI Pharmaceuticals
CASI
$20.5M
| $1.64M | 0.09% |
987,259
|
|